SCHEMBL7721609

SCHEMBL7721609

CCOC(=O)c1nc(Cl)nnc1SC

nearest known ligand 0.42

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
LMNA P02545 3/20 0.42
ALDH1A1 P00352 5/20 0.42
CYP1A2 P05177 1/20 0.42
GLP1R P43220 1/20 0.42
L3MBTL1 Q9Y468 2/20 0.41
GAA P10253 2/20 0.41
KDM4E B2RXH2 1/20 0.41
MAPT P10636 6/20 0.40
NPSR1 Q6W5P4 3/20 0.40
HPGD P15428 2/20 0.40
NPC1 O15118 1/20 0.40
TP53 P04637 1/20 0.40
XBP1 P17861 1/20 0.40
MAPK1 P28482 1/20 0.40
HTT P42858 1/20 0.40
HSD17B10 Q99714 1/20 0.40
TLR9 Q9NR96 1/20 0.40
TARBP2 Q15633 1/20 0.39
TDP1 Q9NUW8 2/20 0.39
POLB P06746 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL31729190 0.75 PTGS1 (0.39) LMNAALDH1A1GLP1RL3MBTL1GAA
SCHEMBL762386 0.73 MAPT (0.58) ALDH1A1L3MBTL1GAAKDM4EMAPT
SCHEMBL31289927 0.72 MEN1 (0.44) LMNAALDH1A1CYP1A2GLP1RKDM4E
SCHEMBL29558416 0.72 MEN1 (0.42) LMNAALDH1A1CYP1A2GLP1RMAPT
SCHEMBL5925649 0.72 MEN1 (0.42) LMNAALDH1A1CYP1A2GLP1RMAPT
SCHEMBL14725188 0.72 ALDH1A1 (0.46) LMNAALDH1A1L3MBTL1GAAKDM4E
SCHEMBL21769050 0.72 LMNA (0.49) LMNAALDH1A1CYP1A2GLP1RGAA
SCHEMBL21679252 0.70 ALDH1A1 (0.43) LMNAALDH1A1CYP1A2GLP1RL3MBTL1
SCHEMBL16398391 0.70 ALDH1A1 (0.43) LMNAALDH1A1CYP1A2GLP1RL3MBTL1
SCHEMBL27029927 0.70 KDM5B (0.46) LMNAALDH1A1CYP1A2GLP1RL3MBTL1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6391885-B1 CONTROLLING APOPTOSIS IN AUTOIMMUNE DISEASE CELL PATHWAYS, INC. 2002-05-21 US disclosed
US-6060477-A Method of treating a patient having precancerous lesions with phenyl cycloamino pyrimidinone derivatives CELL PATHWAYS, INC. (US) 2000-05-09 US disclosed
EP-0347146-B1 FUSED PYRIMIDINE DERIVATIVES, PROCESS AND INTERMEDIATES FOR THEIR PREPARATION AND PHARMACEUTICAL COMPOSITIONS CONTAINING THEM SMITH KLINE & FRENCH LABORATORIES LIMITED (GB) 1993-09-01 EP disclosed
US-5047404-A Fused pyrimidine derivatives bronchodilator agents, antiallergens SMITH KLINE & FRENCH LABORATORIES, LTD. (GB) 1991-09-10 US disclosed
EP-0347146-A2 Fused pyrimidine derivatives, process and intermediates for their preparation and pharmaceutical compositions containing them SMITH KLINE & FRENCH LABORATORIES LIMITED (GB) 1989-12-20 EP disclosed